| Reduced Risk Status: |
|
| IPM Compatibility: |
PER REQUESTOR VERYGOODFIT, NEW FRAC GROUP AND NOT EXPECTED TO BE HARMFUL TO BENEFICIALS; VERY GOOD FIT: SEE PREV COMMENTS.: SOR; VERY GOOD FIT: SEE PREV COMMENTS: NER
|
| Reasons for need: |
POWDERY MILDEW; ROTATIONAL PRODUCT FOR RESISTANCE MANAGEMENT, THIS PRODUCT IS A UNIQUE FRAC GROUP PER CORTEVA PRESENTATION (IR-4 2021)
|
| Requesting State(s): |
FL:Bledsoe, M* ; ME:Bledsoe, M ; WV:Rahman, M ;
|
| PCR Use Pattern: |
GF-4031, 35 -50 G AI/HA, 0.03-0.04 LB AI/A; 20G/L EC; APPLIED FOLIARLY WITH 3 APPLICATIONS AND A 7 DAY RETREATMENT INTERVAL; 0-1 DAY PHI;
|
| EPA Default Residue Trials: |
ANY 4 TRIALS
|
| IR-4 Residue Trial Plan: |
Any 4 trials (large & small)
|
| Residue Protocol Use Pattern: |
USE THE GF-4031 FUNGICIDE PRODUCT (1.67 LB AI/GAL); MAKE 2 FOLIAR DIRECTED APPLIC OF 0.067 LB AI/A, IN AT LEAST 30 GPA, 7-DAY INTERVAL, 1-DAY PHI; ALL APPLIC SHALL INCLUDE A LABELED RATE OF AN ADJUVANT
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
Blue 08/22; Blue: 08/23
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
Residue ongoing, status will be changed to "residue ongoing, E/CS ongoing" once performance protocol is signed 02/24/DRS; E/CS will not be conducted in 2024:08/24/sb
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|